ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Atopic Dermatitis (Eczema) Treatment Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-21T9731
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global Atopic Dermatitis Eczema Treatment Market Research Report 2022
BUY CHAPTERS

Global Atopic Dermatitis (Eczema) Treatment Market Research Report 2024

Code: QYRE-Auto-21T9731
Report
June 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Allergan plc
Novartis
Bristol–Myers Squibb
Bayer
Meda Pharmaceuticals
Anacor Pharmaceutical
Pfizer Inc
Astellas Pharma
Regeneron Pharmaceuticals

Atopic Dermatitis (Eczema) Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Atopic Dermatitis (Eczema) Treatment Market

Atopic Dermatitis (Eczema) Treatment Market

Atopic dermatitis is a chronic disease that causes inflammation of the skin and results in red, itchy, swollen, and cracked skin.
Market Snapshot
The global Atopic Dermatitis (Eczema) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Atopic Dermatitis (Eczema) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atopic Dermatitis (Eczema) Treatment.

Report Scope

The Atopic Dermatitis (Eczema) Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Atopic Dermatitis (Eczema) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atopic Dermatitis (Eczema) Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Atopic Dermatitis (Eczema) Treatment Market Report

Report Metric Details
Report Name Atopic Dermatitis (Eczema) Treatment Market
CAGR 5%
Segment by Type
  • Topical
  • Oral
  • Injectable
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Allergan, Novartis, Bristol Myers Squibb, Bayer, Meda Pharmaceuticals, Anacor Pharmaceutical, Pfizer, Astellas Pharma, Regeneron Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Atopic Dermatitis (Eczema) Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Atopic Dermatitis (Eczema) Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Atopic Dermatitis (Eczema) Treatment Market report?

Ans: The main players in the Atopic Dermatitis (Eczema) Treatment Market are Sanofi, Allergan, Novartis, Bristol Myers Squibb, Bayer, Meda Pharmaceuticals, Anacor Pharmaceutical, Pfizer, Astellas Pharma, Regeneron Pharmaceuticals

What are the Application segmentation covered in the Atopic Dermatitis (Eczema) Treatment Market report?

Ans: The Applications covered in the Atopic Dermatitis (Eczema) Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Atopic Dermatitis (Eczema) Treatment Market report?

Ans: The Types covered in the Atopic Dermatitis (Eczema) Treatment Market report are Topical, Oral, Injectable

1 Atopic Dermatitis (Eczema) Treatment Market Overview
1.1 Product Overview and Scope of Atopic Dermatitis (Eczema) Treatment
1.2 Atopic Dermatitis (Eczema) Treatment Segment by Type
1.2.1 Global Atopic Dermatitis (Eczema) Treatment Market Value Comparison by Type (2024-2030)
1.2.2 Topical
1.2.3 Oral
1.2.4 Injectable
1.3 Atopic Dermatitis (Eczema) Treatment Segment by Application
1.3.1 Global Atopic Dermatitis (Eczema) Treatment Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Atopic Dermatitis (Eczema) Treatment Market Size Estimates and Forecasts
1.4.1 Global Atopic Dermatitis (Eczema) Treatment Revenue 2019-2030
1.4.2 Global Atopic Dermatitis (Eczema) Treatment Sales 2019-2030
1.4.3 Global Atopic Dermatitis (Eczema) Treatment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Atopic Dermatitis (Eczema) Treatment Market Competition by Manufacturers
2.1 Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Atopic Dermatitis (Eczema) Treatment Average Price by Manufacturers (2019-2024)
2.4 Global Atopic Dermatitis (Eczema) Treatment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atopic Dermatitis (Eczema) Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atopic Dermatitis (Eczema) Treatment, Product Type & Application
2.7 Atopic Dermatitis (Eczema) Treatment Market Competitive Situation and Trends
2.7.1 Atopic Dermatitis (Eczema) Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Atopic Dermatitis (Eczema) Treatment Players Market Share by Revenue
2.7.3 Global Atopic Dermatitis (Eczema) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Atopic Dermatitis (Eczema) Treatment Retrospective Market Scenario by Region
3.1 Global Atopic Dermatitis (Eczema) Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Atopic Dermatitis (Eczema) Treatment Global Atopic Dermatitis (Eczema) Treatment Sales by Region: 2019-2030
3.2.1 Global Atopic Dermatitis (Eczema) Treatment Sales by Region: 2019-2024
3.2.2 Global Atopic Dermatitis (Eczema) Treatment Sales by Region: 2025-2030
3.3 Global Atopic Dermatitis (Eczema) Treatment Global Atopic Dermatitis (Eczema) Treatment Revenue by Region: 2019-2030
3.3.1 Global Atopic Dermatitis (Eczema) Treatment Revenue by Region: 2019-2024
3.3.2 Global Atopic Dermatitis (Eczema) Treatment Revenue by Region: 2025-2030
3.4 North America Atopic Dermatitis (Eczema) Treatment Market Facts & Figures by Country
3.4.1 North America Atopic Dermatitis (Eczema) Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Atopic Dermatitis (Eczema) Treatment Sales by Country (2019-2030)
3.4.3 North America Atopic Dermatitis (Eczema) Treatment Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Atopic Dermatitis (Eczema) Treatment Market Facts & Figures by Country
3.5.1 Europe Atopic Dermatitis (Eczema) Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Atopic Dermatitis (Eczema) Treatment Sales by Country (2019-2030)
3.5.3 Europe Atopic Dermatitis (Eczema) Treatment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atopic Dermatitis (Eczema) Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Atopic Dermatitis (Eczema) Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Atopic Dermatitis (Eczema) Treatment Sales by Country (2019-2030)
3.6.3 Asia Pacific Atopic Dermatitis (Eczema) Treatment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Atopic Dermatitis (Eczema) Treatment Market Facts & Figures by Country
3.7.1 Latin America Atopic Dermatitis (Eczema) Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Atopic Dermatitis (Eczema) Treatment Sales by Country (2019-2030)
3.7.3 Latin America Atopic Dermatitis (Eczema) Treatment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atopic Dermatitis (Eczema) Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Atopic Dermatitis (Eczema) Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Atopic Dermatitis (Eczema) Treatment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Atopic Dermatitis (Eczema) Treatment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Atopic Dermatitis (Eczema) Treatment Sales by Type (2019-2030)
4.1.1 Global Atopic Dermatitis (Eczema) Treatment Sales by Type (2019-2024)
4.1.2 Global Atopic Dermatitis (Eczema) Treatment Sales by Type (2025-2030)
4.1.3 Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Type (2019-2030)
4.2 Global Atopic Dermatitis (Eczema) Treatment Revenue by Type (2019-2030)
4.2.1 Global Atopic Dermatitis (Eczema) Treatment Revenue by Type (2019-2024)
4.2.2 Global Atopic Dermatitis (Eczema) Treatment Revenue by Type (2025-2030)
4.2.3 Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Atopic Dermatitis (Eczema) Treatment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Atopic Dermatitis (Eczema) Treatment Sales by Application (2019-2030)
5.1.1 Global Atopic Dermatitis (Eczema) Treatment Sales by Application (2019-2024)
5.1.2 Global Atopic Dermatitis (Eczema) Treatment Sales by Application (2025-2030)
5.1.3 Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Application (2019-2030)
5.2 Global Atopic Dermatitis (Eczema) Treatment Revenue by Application (2019-2030)
5.2.1 Global Atopic Dermatitis (Eczema) Treatment Revenue by Application (2019-2024)
5.2.2 Global Atopic Dermatitis (Eczema) Treatment Revenue by Application (2025-2030)
5.2.3 Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Atopic Dermatitis (Eczema) Treatment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Atopic Dermatitis (Eczema) Treatment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Atopic Dermatitis (Eczema) Treatment Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Atopic Dermatitis (Eczema) Treatment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Allergan Atopic Dermatitis (Eczema) Treatment Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Atopic Dermatitis (Eczema) Treatment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Atopic Dermatitis (Eczema) Treatment Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Bristol Myers Squibb
6.4.1 Bristol Myers Squibb Corporation Information
6.4.2 Bristol Myers Squibb Description and Business Overview
6.4.3 Bristol Myers Squibb Atopic Dermatitis (Eczema) Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol Myers Squibb Atopic Dermatitis (Eczema) Treatment Product Portfolio
6.4.5 Bristol Myers Squibb Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Atopic Dermatitis (Eczema) Treatment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer Atopic Dermatitis (Eczema) Treatment Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Meda Pharmaceuticals
6.6.1 Meda Pharmaceuticals Corporation Information
6.6.2 Meda Pharmaceuticals Description and Business Overview
6.6.3 Meda Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Meda Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Product Portfolio
6.6.5 Meda Pharmaceuticals Recent Developments/Updates
6.7 Anacor Pharmaceutical
6.6.1 Anacor Pharmaceutical Corporation Information
6.6.2 Anacor Pharmaceutical Description and Business Overview
6.6.3 Anacor Pharmaceutical Atopic Dermatitis (Eczema) Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Anacor Pharmaceutical Atopic Dermatitis (Eczema) Treatment Product Portfolio
6.7.5 Anacor Pharmaceutical Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Atopic Dermatitis (Eczema) Treatment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Atopic Dermatitis (Eczema) Treatment Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Astellas Pharma
6.9.1 Astellas Pharma Corporation Information
6.9.2 Astellas Pharma Description and Business Overview
6.9.3 Astellas Pharma Atopic Dermatitis (Eczema) Treatment Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Astellas Pharma Atopic Dermatitis (Eczema) Treatment Product Portfolio
6.9.5 Astellas Pharma Recent Developments/Updates
6.10 Regeneron Pharmaceuticals
6.10.1 Regeneron Pharmaceuticals Corporation Information
6.10.2 Regeneron Pharmaceuticals Description and Business Overview
6.10.3 Regeneron Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Regeneron Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Product Portfolio
6.10.5 Regeneron Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atopic Dermatitis (Eczema) Treatment Industry Chain Analysis
7.2 Atopic Dermatitis (Eczema) Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atopic Dermatitis (Eczema) Treatment Production Mode & Process
7.4 Atopic Dermatitis (Eczema) Treatment Sales and Marketing
7.4.1 Atopic Dermatitis (Eczema) Treatment Sales Channels
7.4.2 Atopic Dermatitis (Eczema) Treatment Distributors
7.5 Atopic Dermatitis (Eczema) Treatment Customers
8 Atopic Dermatitis (Eczema) Treatment Market Dynamics
8.1 Atopic Dermatitis (Eczema) Treatment Industry Trends
8.2 Atopic Dermatitis (Eczema) Treatment Market Drivers
8.3 Atopic Dermatitis (Eczema) Treatment Market Challenges
8.4 Atopic Dermatitis (Eczema) Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
Allergan plc
Novartis
Bristol–Myers Squibb
Bayer
Meda Pharmaceuticals
Anacor Pharmaceutical
Pfizer Inc
Astellas Pharma
Regeneron Pharmaceuticals
List of Tables
    Table 1. Global Atopic Dermatitis (Eczema) Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Atopic Dermatitis (Eczema) Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Atopic Dermatitis (Eczema) Treatment Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Atopic Dermatitis (Eczema) Treatment Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Atopic Dermatitis (Eczema) Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Atopic Dermatitis (Eczema) Treatment Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Atopic Dermatitis (Eczema) Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Atopic Dermatitis (Eczema) Treatment, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Atopic Dermatitis (Eczema) Treatment, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Atopic Dermatitis (Eczema) Treatment, Product Type & Application
    Table 12. Global Key Manufacturers of Atopic Dermatitis (Eczema) Treatment, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Atopic Dermatitis (Eczema) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atopic Dermatitis (Eczema) Treatment as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Atopic Dermatitis (Eczema) Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Atopic Dermatitis (Eczema) Treatment Sales by Region (2019-2024) & (K Units)
    Table 18. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Region (2019-2024)
    Table 19. Global Atopic Dermatitis (Eczema) Treatment Sales by Region (2025-2030) & (K Units)
    Table 20. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Region (2025-2030)
    Table 21. Global Atopic Dermatitis (Eczema) Treatment Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Region (2019-2024)
    Table 23. Global Atopic Dermatitis (Eczema) Treatment Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Region (2025-2030)
    Table 25. North America Atopic Dermatitis (Eczema) Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Atopic Dermatitis (Eczema) Treatment Sales by Country (2019-2024) & (K Units)
    Table 27. North America Atopic Dermatitis (Eczema) Treatment Sales by Country (2025-2030) & (K Units)
    Table 28. North America Atopic Dermatitis (Eczema) Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Atopic Dermatitis (Eczema) Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Atopic Dermatitis (Eczema) Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Atopic Dermatitis (Eczema) Treatment Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Atopic Dermatitis (Eczema) Treatment Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Atopic Dermatitis (Eczema) Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Atopic Dermatitis (Eczema) Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Atopic Dermatitis (Eczema) Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Atopic Dermatitis (Eczema) Treatment Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Atopic Dermatitis (Eczema) Treatment Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Atopic Dermatitis (Eczema) Treatment Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Atopic Dermatitis (Eczema) Treatment Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Atopic Dermatitis (Eczema) Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Atopic Dermatitis (Eczema) Treatment Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Atopic Dermatitis (Eczema) Treatment Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Atopic Dermatitis (Eczema) Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Atopic Dermatitis (Eczema) Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Atopic Dermatitis (Eczema) Treatment Sales (K Units) by Type (2019-2024)
    Table 51. Global Atopic Dermatitis (Eczema) Treatment Sales (K Units) by Type (2025-2030)
    Table 52. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Type (2019-2024)
    Table 53. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Type (2025-2030)
    Table 54. Global Atopic Dermatitis (Eczema) Treatment Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Atopic Dermatitis (Eczema) Treatment Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Type (2019-2024)
    Table 57. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Type (2025-2030)
    Table 58. Global Atopic Dermatitis (Eczema) Treatment Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Atopic Dermatitis (Eczema) Treatment Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Atopic Dermatitis (Eczema) Treatment Sales (K Units) by Application (2019-2024)
    Table 61. Global Atopic Dermatitis (Eczema) Treatment Sales (K Units) by Application (2025-2030)
    Table 62. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Application (2019-2024)
    Table 63. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Application (2025-2030)
    Table 64. Global Atopic Dermatitis (Eczema) Treatment Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Atopic Dermatitis (Eczema) Treatment Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Application (2019-2024)
    Table 67. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Application (2025-2030)
    Table 68. Global Atopic Dermatitis (Eczema) Treatment Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Atopic Dermatitis (Eczema) Treatment Price (US$/Unit) by Application (2025-2030)
    Table 70. Sanofi Corporation Information
    Table 71. Sanofi Description and Business Overview
    Table 72. Sanofi Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Sanofi Atopic Dermatitis (Eczema) Treatment Product
    Table 74. Sanofi Recent Developments/Updates
    Table 75. Allergan Corporation Information
    Table 76. Allergan Description and Business Overview
    Table 77. Allergan Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Allergan Atopic Dermatitis (Eczema) Treatment Product
    Table 79. Allergan Recent Developments/Updates
    Table 80. Novartis Corporation Information
    Table 81. Novartis Description and Business Overview
    Table 82. Novartis Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Novartis Atopic Dermatitis (Eczema) Treatment Product
    Table 84. Novartis Recent Developments/Updates
    Table 85. Bristol Myers Squibb Corporation Information
    Table 86. Bristol Myers Squibb Description and Business Overview
    Table 87. Bristol Myers Squibb Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Bristol Myers Squibb Atopic Dermatitis (Eczema) Treatment Product
    Table 89. Bristol Myers Squibb Recent Developments/Updates
    Table 90. Bayer Corporation Information
    Table 91. Bayer Description and Business Overview
    Table 92. Bayer Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Bayer Atopic Dermatitis (Eczema) Treatment Product
    Table 94. Bayer Recent Developments/Updates
    Table 95. Meda Pharmaceuticals Corporation Information
    Table 96. Meda Pharmaceuticals Description and Business Overview
    Table 97. Meda Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Meda Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Product
    Table 99. Meda Pharmaceuticals Recent Developments/Updates
    Table 100. Anacor Pharmaceutical Corporation Information
    Table 101. Anacor Pharmaceutical Description and Business Overview
    Table 102. Anacor Pharmaceutical Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Anacor Pharmaceutical Atopic Dermatitis (Eczema) Treatment Product
    Table 104. Anacor Pharmaceutical Recent Developments/Updates
    Table 105. Pfizer Corporation Information
    Table 106. Pfizer Description and Business Overview
    Table 107. Pfizer Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Pfizer Atopic Dermatitis (Eczema) Treatment Product
    Table 109. Pfizer Recent Developments/Updates
    Table 110. Astellas Pharma Corporation Information
    Table 111. Astellas Pharma Description and Business Overview
    Table 112. Astellas Pharma Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Astellas Pharma Atopic Dermatitis (Eczema) Treatment Product
    Table 114. Astellas Pharma Recent Developments/Updates
    Table 115. Regeneron Pharmaceuticals Corporation Information
    Table 116. Regeneron Pharmaceuticals Description and Business Overview
    Table 117. Regeneron Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Regeneron Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Product
    Table 119. Regeneron Pharmaceuticals Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Atopic Dermatitis (Eczema) Treatment Distributors List
    Table 123. Atopic Dermatitis (Eczema) Treatment Customers List
    Table 124. Atopic Dermatitis (Eczema) Treatment Market Trends
    Table 125. Atopic Dermatitis (Eczema) Treatment Market Drivers
    Table 126. Atopic Dermatitis (Eczema) Treatment Market Challenges
    Table 127. Atopic Dermatitis (Eczema) Treatment Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Atopic Dermatitis (Eczema) Treatment
    Figure 2. Global Atopic Dermatitis (Eczema) Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Atopic Dermatitis (Eczema) Treatment Market Share by Type in 2023 & 2030
    Figure 4. Topical Product Picture
    Figure 5. Oral Product Picture
    Figure 6. Injectable Product Picture
    Figure 7. Global Atopic Dermatitis (Eczema) Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Atopic Dermatitis (Eczema) Treatment Market Share by Application in 2023 & 2030
    Figure 9. Hospital Pharmacies
    Figure 10. Retail Pharmacies
    Figure 11. Online Pharmacies
    Figure 12. Global Atopic Dermatitis (Eczema) Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Atopic Dermatitis (Eczema) Treatment Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Atopic Dermatitis (Eczema) Treatment Sales (2019-2030) & (K Units)
    Figure 15. Global Atopic Dermatitis (Eczema) Treatment Average Price (US$/Unit) & (2019-2030)
    Figure 16. Atopic Dermatitis (Eczema) Treatment Report Years Considered
    Figure 17. Atopic Dermatitis (Eczema) Treatment Sales Share by Manufacturers in 2023
    Figure 18. Global Atopic Dermatitis (Eczema) Treatment Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Atopic Dermatitis (Eczema) Treatment Players: Market Share by Revenue in 2023
    Figure 20. Atopic Dermatitis (Eczema) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Atopic Dermatitis (Eczema) Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Atopic Dermatitis (Eczema) Treatment Sales Market Share by Country (2019-2030)
    Figure 23. North America Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Country (2019-2030)
    Figure 24. U.S. Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Atopic Dermatitis (Eczema) Treatment Sales Market Share by Country (2019-2030)
    Figure 27. Europe Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Atopic Dermatitis (Eczema) Treatment Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Region (2019-2030)
    Figure 35. China Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Taiwan Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Philippines Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Atopic Dermatitis (Eczema) Treatment Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. U.A.E Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Atopic Dermatitis (Eczema) Treatment by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Atopic Dermatitis (Eczema) Treatment by Type (2019-2030)
    Figure 57. Global Atopic Dermatitis (Eczema) Treatment Price (US$/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Atopic Dermatitis (Eczema) Treatment by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Atopic Dermatitis (Eczema) Treatment by Application (2019-2030)
    Figure 60. Global Atopic Dermatitis (Eczema) Treatment Price (US$/Unit) by Application (2019-2030)
    Figure 61. Atopic Dermatitis (Eczema) Treatment Value Chain
    Figure 62. Atopic Dermatitis (Eczema) Treatment Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Scar Creams and Scar Gels - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-35Q13902
Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Patch Type Medical Skin Repair Dressing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39X12870
Sat Oct 05 00:00:00 UTC 2024

Add to Cart

Lentigo Maligna Melanoma Therapeutic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-3N13952
Tue Oct 01 00:00:00 UTC 2024

Add to Cart

Global Fragrance-free Diaper Rash Cream Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-16R18271
Thu Sep 26 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions